Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

52results about How to "Improved disintegration time" patented technology

Vonoprazan oral quick-dissolving film agent and method for preparing same

The invention discloses a Vonoprazan oral quick-dissolving film agent and a method for preparing the same, and belongs to the field of medicine preparations.The Vonoprazan oral quick-dissolving film agent particularly comprises, by weight, 10-15% of Vonoprazan active monomers, 50-55% of hydroxypropyl methylcellulose, 25-30% of maltodextrin, 0.8-1.0% of hyaluronic acid and 5-10% of plasticizers.The Vonoprazan oral quick-dissolving film agent and the method have the advantages that the water-soluble hydroxypropyl methylcellulose, the water-soluble maltodextrin and the water-soluble hyaluronic acid are preferably used as film-forming materials, the appropriate plasticizers with the appropriate weight ratio are screened, and accordingly the film agent with excellent disintegration time and excellent mechanical performance can be prepared; the disintegration time limit of the Vonoprazan oral quick-dissolving film agent can be obviously shortened, accordingly, the shortcoming that water is required when existing most oral solid preparations are about to be administered can be overcome, the medicine administration time cannot be delayed even under the condition of deficiency of water resources, and the medication compliance of patients can be improved.
Owner:NANJING GRITPHARMA CO LTD

Medicament for treating metrorrhagia and metrostaxis, hematemesis, hematochezia and traumatic hemorrhage and preparation method thereof

The invention relates to a medicament for treating metrorrhagia and metrostaxis, hematemesis, hematochezia and traumatic hemorrhage and a preparation method thereof. The preparation method comprises the following steps of: 1, mixing rhubarb, golden thread and dahurian angelica root, adding an ethanol, merging ethanol extract, and concentrating the ethanol extract; 2, adding sanchi into the ethanol, merging ethanol extract and concentrating the ethanol extract; 3, taking common bletilla pseudobulb decocting liquid and concentrating the liquid into a thick paste with a relative density between 1.15 and 1.30 at the temperature of 60 DEG C; 4, decocting dregs in the three steps, India madder root and liquoric root twice, merging decoction, concentrating the decoction, mixing the concentrated decoction with the thick paste obtained in step 3, reducing pressure and drying the mixture to obtain a dry paste and crushing the dry paste; 5, evenly mixing products obtained by step 1 and step 2, carrying out high-speed centrifugal spraying drying, and simultaneously spraying aqueous solution of hydroxypropyl-beta-cyclodextrin to prepare dispersed fine powder; and 6, mixing and crushing medicaments such as cuttlebone, calcined dragon bone and the like, evenly mixing the mixture with two fine powder obtained by the step 4 and step 5, adding medicaments such as microcrystalline cellulose and the like, and evenly mixing, drying and palletizing the mixture. The medicament simplifies production process, saves production cost and has obvious curative effect.
Owner:XIAN CHIHO PHARMA

Method for improving disintegration time limit of fuke qianjin tablet

The invention discloses a method for improving disintegration time limit of fuke qianjin tablet. The fuke qianjin tablet is prepared from the following raw materials: philippine flemingia root, Chinese mahonia stem, herba andrographitis, folium zanthoxyli dissiti, caulis spatholobi, radix angelicae sinensis, radix codonopsis pilosulae and Cherokee rose root. During the preparation process of the fuke qianjin tablet, the content of Z-3-butylidene phthalide and the total volume of andrographolide and dehydrated andrographolide are regulated; in each fuke qianjin tablet, the content of Z-3-butylidene phthalide is not less than 0.015mg and the total volume of andrographolide and dehydrated andrographolide is not less than 1.1mg; HPLC method is optimally adopted for detecting the content. According to the invention, the important influences of the content of Z-3-butylidene phthalide and the total volume of andrographolide and dehydrated andrographolide in the fuke qianjin tablet on the product performances are confirmed and the accurate limitation is performed. Compared with the present fuke qianjin tablet, the fuke qianjin tablet prepared according to the invention has the advantages that the disintegration time limit is improved, the active ingredients are quickly released and can quickly take effect, and the clinical efficacy is further promoted.
Owner:ZHUZHOU QIANJIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products